← FDA WARNING LETTERS
FDA WARNING LETTER4 August 2026
ABS Corporation — FDA Warning Letter
CGMP/Finished Pharmaceuticals/Adulterated
What this record is not
Warning-letter details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.
Company
ABS Corporation
Letter date
4 August 2026
Issuing office
Center for Veterinary Medicine
What this signals · SPEQ interpretation
SPEQ reads this warning letter’s stated subject as touching current good manufacturing practice. That is a keyword reading of the published subject, not an official classification — the requirements and playbooks below are where a team would look to prevent or close it.
Requirements behind it
Decode the practice
DisciplinesGMP
READ THE FULL LETTER
The complete warning letter, including every cited observation, is published by the FDA. SPEQ surfaces and indexes it for reference — the authoritative text lives on fda.gov.
View on fda.gov →